Carneiro C, Brito J, Bilreiro C, Barros M, Bahia C, Santiago I, et al. All about portal vein: a pictorial display to anatomy, variants and physiopathology. Insights Imaging 2019;10(1):38. Published online 2019 Mar 21.
DOI: 10.1186/s13244-019-0716-8
Corness JA, McHugh K, Roebuck DJ, Taylor AM. The portal vein in children: radiological review of congenital anomalies and acquired abnormalities. Pediatr Radiol 2006;36(2):87-171.
DOI: 10.1007/s00247-005-0010-4
Valeriani E, Riva N, Di Nisio M, Ageno W. Splanchnic vein thrombosis: Current perspectives. Vasc Health Risk Manag 2019;15:449-61. Published 2019 Oct 22.
DOI: 10.2147/VHRM.S197732
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol 2016;64(1):179-202.
DOI: 10.1016/j.jhep.2015.07.040
Northup PG, García-Pagán JC, García-Tsao G, Intagliata NM, Superina RA, Roberts LN, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73(1):366-413.
DOI: 10.1002/hep.31646
Plessier A, Darwish-Murad S, Hernández-Guerra M, Consigny Y, Fabris F, Trebicka J, et al. Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study. Hepatology 2010;51(1):210-8.
DOI: 10.1002/hep.23259
Yerdel MA, Gunson B, Mirza D, K Karayalçin, S Olliff, J Buckels, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 2000;69(9):1873-81.
DOI: 10.1097/00007890-200005150-00023
Ageno W, Dentali F, Pomero F, Fenoglio L, Squizzato A, Pagani G, et al. Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome. Thromb Haemost 2017;117(4):794-800.
DOI: 10.1160/TH16-10-0781
Ogren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 2006;12(13):2115-9.
DOI: 10.3748/wjg.v12.i13.2115
Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N, et al. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 1985;89(2):279-86.
DOI: 10.1016/0016-5085(85)90327-0
Nery F, Chevret S, Condat B, Raucourt E, Boudaoud L, Rautou PE, et al. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study. Hepatology 2015;61(2):660-7.
DOI: 10.1002/hep.27546
Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 2001;120(2):490-7.
DOI: 10.1053/gast.2001.21209
Chamouard P, Pencreach E, Maloisel F, Grunebaum L, Ardizzone JF, Meyer A, et al. Frequent factor II G20210A mutation in idiopathic portal vein thrombosis. Gastroenterology 1999;116(1):144-8.
DOI: 10.1016/S0016-5085(99)70238-6
Janssen HL, Meinardi JR, Vleggaar FP, van Uun SH, Haagsma EB, van Der Meer FJ, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000;96(7):2364-8.
Primignani M, Martinelli I, Bucciarelli P, Reati R, Fabris F, Dell’era A, et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 2005;41(3):603-8.
DOI: 10.1002/hep.20591
Denninger MH, Chaït Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000;31(3):587-91.
DOI: 10.1002/hep.510310307
Plemmons RM, Dooley DP, Longfield RN. Septic thrombophlebitis of the portal vein (pylephlebitis): diagnosis and management in the modern era. Clin Infect Dis 1995;21(5):1114-20.
DOI: 10.1093/clinids/21.5.1114
Webb LJ, Sherlock S. The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med 1979;48(192):627-39.
Bhattacharyya M, Makharia G, Kannan M, Ahmed RP, Gupta PK, Saxena R. Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India. Am J Clin Pathol 2004;121(6):844-7.
DOI: 10.1309/F2U1XBV4RXYUAYG0
Shrestha SM, Okuda K, Uchida T, Maharjan KG, Shrestha S, Joshi BL, et al. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol 1996;11(2):170-9.
DOI: 10.1111/j.1440-1746.1996.tb00056.x
DeLeve LD, Valla DC, García-Tsao G; American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology 2009;49(5):1729-64.
DOI: 10.1002/hep.22772
Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Di Maurizio L, et al. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol 2010;16(2):143-55.
DOI: 10.3748/wjg.v16.i2.143
Henderson JM, Gilmore GT, Mackay GJ, Galloway JR, Dodson TF, Kutner MH. Hemodynamics during liver transplantation: the interactions between cardiac output and portal venous and hepatic arterial flows. Hepatology 1992;16(3):715-8.
DOI: 10.1002/hep.1840160316
Ohnishi K, Okuda K, Ohtsuki T, Nakayama T, Hiyama Y, Iwama S, et al. Formation of hilar collaterals or cavernous transformation after portal vein obstruction by hepatocellular carcinoma. Observations in ten patients. Gastroenterology 1984;87(5):1150-3.
DOI: 10.1016/S0016-5085(84)80077-3
De Gaetano AM, Lafortune M, Patriquin H, De Franco A, Aubin B, Paradis K. Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography. AJR Am J Roentgenol 1995;165(5):1151-5.
DOI: 10.2214/ajr.165.5.7572494
Anton A, Campreciós G, Pérez-Campuzano V, Orts L, García-Pagán JC, Hernández-Gea V. The pathophysiology of portal vein thrombosis in cirrhosis: Getting Deeper into Virchow’s Triad. J Clin Med 2022;11(3):800. Published 2022 Feb 2.
DOI: 10.3390/jcm11030800
Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 2010;116(6):878-85.
DOI: 10.1182/blood-2010-02-261891
Tripodi A, Primignani M, Chantarangkul V, Dell’Era A, Clerici M, de Franchis R, et al. An imbalance of pro- vs anti- coagulation factors in plasma from patients with cirrhosis. Gastroenterology 2009;137(6):2105-11.
DOI: 10.1053/j.gastro.2009.08.045
Maruyama H, Okugawa H, Takahashi M, Yokosuka O. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol 2013;108(4):568-74.
DOI: 10.1038/ajg.2012.452
García-Pagán JC, Gracia-Sancho J, Bosch J. Functional aspects on the pathophysiology of portal hypertension in cirrhosis. J Hepatol 2012;57(2):458-61.
DOI: 10.1016/j.jhep.2012.03.007
Haag K, Rössle M, Ochs A, Huber M, Siegertetter V, Olschewski M, et al. Correlation of duplex sonography findings and portal pressure in 375 patients with portal hypertension. AJR Am J Roentgenol 1999;172(3):631-5.
DOI: 10.2214/ajr.172.3.10063849
Bosch J, Abraldes JG, Fernández M, García-Pagán JC. Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension. J Hepatol 2010;53(3):558-67.
DOI: 10.1016/j.jhep.2010.03.021
Badimon L, Vilahur G. Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med 2014;276(6):618-32.
DOI: 10.1111/joim.12296
Driever EG, von Meijenfeldt FA, Adelmeijer J, de Haas RJ, van den Heuvel MC, Nagasami C, et al. Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus. Hepatology 2022;75(4):898-911.
DOI: 10.1002/hep.32169
Lippi G, Favaloro EJ. Venous and Arterial Thromboses: Two Sides of the Same Coin? Semin Thromb Hemost 2018;44(3):239-48.
DOI: 10.1055/s-0037-1607202
De Stefano V, Martinelli I. Splanchnic vein thrombosis: clinical presentation, risk factors and treatment. Intern Emerg Med 2010;5(6):487-94.
DOI: 10.1007/s11739-010-0413-6
Hoekstra J, Janssen HL. Vascular liver disorders (II): portal vein thrombosis. Neth J Med 2009;67(2):46-53.
Riva N, Ageno W. Clinical manifestations and imaging tools in the diagnosis of splanchnic and cerebral vein thromboses. Thromb Res 2018;163:252-9.
DOI: 10.1016/j.thromres.2017.06.030
Tessler FN, Gehring BJ, Gomes AS, Perella RR, Ragavendra N, Busuttil RW, et al. Diagnosis of portal vein thrombosis: value of color Doppler imaging. AJR Am J Roentgenol 1991;157(2):293-6.
DOI: 10.2214/ajr.157.2.1853809
Van Gansbeke D, Avni EF, Delcour C, Engelholm L, Struyven J. Sonographic features of portal vein thrombosis. AJR Am J Roentgenol 1985;144(4):749-52.
DOI: 10.2214/ajr.144.4.749
Simonetto DA, Singal AK, García-Tsao G, Caldwell SH, Ahn J, Kamath PS. ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation. Am J Gastroenterol 2020;115(1):18-40.
DOI: 10.14309/ajg.0000000000000486
Bach AM, Hann LE, Brown KT, Getrajdman GI, Herman SK, Fong Y, et al. Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology 1996;201(1):149-54.
DOI: 10.1148/radiology.201.1.8816536
Kreft B, Strunk H, Flacke S, Wolff M, Conrad R, Gieseke R, et al. Detection of thrombosis in the portal venous system: comparison of contrast-enhanced MR angiography with intraarterial digital subtraction angiography. Radiology 2000;216(1):86-92.
DOI: 10.1148/radiology.216.1.r00jl2386
Cakmak O, Elmas N, Tamsel S, Demirpolart G, Sever A, Altunel E, et al. Role of contrast-enhanced 3D magnetic resonance portography in evaluating portal venous system compared with color Doppler ultrasonography. Abdom Imaging 2008;33(1):65-71.
DOI: 10.1007/s00261-007-9229-x
Condat B, Valla D. Nonmalignant portal vein thrombosis in adults. Nat Clin Pract Gastroenterol Hepatol 2006;3(9):505-15.
DOI: 10.1038/ncpgasthep0577
Kocher G, Himmelmann A. Portal vein thrombosis (PVT): a study of 20 non-cirrhotic cases. Swiss Med Wkly 2005;135(25-26):372-6.
DOI: 10.4414/smw.2005.11035
Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Troy K, Schiano T, et al. The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis. Blood Adv 2020;4(4):655-66.
DOI: 10.1182/bloodadvances.2019001310
Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 2000;32(3):466-70.
DOI: 10.1053/jhep.2000.16597
Galante A, De Gottardi A. Portal vein thrombosis: an overview of current treatment options. Acta Gastroenterol Belg 2021;84(2):327-32.
DOI: 10.51821/84.2.327
La Mura V, Braham S, Tosetti G, Branchi F, Bitto N, Moia M, et al. Harmful and beneficial effects of anticoagulants in patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol 2018;16(7):1146-52.e4.
DOI: 10.1016/j.cgh.2017.10.016
Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis. Gastroenterology 2019;156(6):1582-99.e1.
DOI: 10.1053/j.gastro.2019.01.265
Valeriani E, Di Nisio M, Riva N, Cohen O, Porreca E, Senzolo M, et al. Anticoagulant treatment for splanchnic vein thrombosis in liver cirrhosis: A systematic review and meta-analysis. Thromb Haemost 2021;121(7):867-76.
DOI: 10.1055/s-0040-1722192
Hanafy AS, Abd-Elsalam S, Dawoud MM. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis. Vascul Pharmacol 2019;113:86-91.
DOI: 10.1016/j.vph.2018.05.002
Lip GYH, Lane DA. Matching the NOAC to the Patient: Remember the Modifiable Bleeding Risk Factors. J Am Coll Cardiol 2015;66(21):2282-4.
DOI: 10.1016/j.jacc.2015.07.086
Número de descargas:
88
Número de visitas:
242
Citas:
0
